Cargando…

The Epigenetic Role of Vitamin C in Neurodevelopment

The maternal diet during pregnancy is a key determinant of offspring health. Early studies have linked poor maternal nutrition during gestation with a propensity for the development of chronic conditions in offspring. These conditions include cardiovascular disease, type 2 diabetes and even compromi...

Descripción completa

Detalles Bibliográficos
Autores principales: Coker, Sharna J., Smith-Díaz, Carlos C., Dyson, Rebecca M., Vissers, Margreet C. M., Berry, Mary J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836017/
https://www.ncbi.nlm.nih.gov/pubmed/35163133
http://dx.doi.org/10.3390/ijms23031208
_version_ 1784649573828919296
author Coker, Sharna J.
Smith-Díaz, Carlos C.
Dyson, Rebecca M.
Vissers, Margreet C. M.
Berry, Mary J.
author_facet Coker, Sharna J.
Smith-Díaz, Carlos C.
Dyson, Rebecca M.
Vissers, Margreet C. M.
Berry, Mary J.
author_sort Coker, Sharna J.
collection PubMed
description The maternal diet during pregnancy is a key determinant of offspring health. Early studies have linked poor maternal nutrition during gestation with a propensity for the development of chronic conditions in offspring. These conditions include cardiovascular disease, type 2 diabetes and even compromised mental health. While multiple factors may contribute to these outcomes, disturbed epigenetic programming during early development is one potential biological mechanism. The epigenome is programmed primarily in utero, and during this time, the developing fetus is highly susceptible to environmental factors such as nutritional insults. During neurodevelopment, epigenetic programming coordinates the formation of primitive central nervous system structures, neurogenesis, and neuroplasticity. Dysregulated epigenetic programming has been implicated in the aetiology of several neurodevelopmental disorders such as Tatton-Brown-Rahman syndrome. Accordingly, there is great interest in determining how maternal nutrient availability in pregnancy might affect the epigenetic status of offspring, and how such influences may present phenotypically. In recent years, a number of epigenetic enzymes that are active during embryonic development have been found to require vitamin C as a cofactor. These enzymes include the ten-eleven translocation methylcytosine dioxygenases (TETs) and the Jumonji C domain-containing histone lysine demethylases that catalyse the oxidative removal of methyl groups on cytosines and histone lysine residues, respectively. These enzymes are integral to epigenetic regulation and have fundamental roles in cellular differentiation, the maintenance of pluripotency and development. The dependence of these enzymes on vitamin C for optimal catalytic activity illustrates a potentially critical contribution of the nutrient during mammalian development. These insights also highlight a potential risk associated with vitamin C insufficiency during pregnancy. The link between vitamin C insufficiency and development is particularly apparent in the context of neurodevelopment and high vitamin C concentrations in the brain are indicative of important functional requirements in this organ. Accordingly, this review considers the evidence for the potential impact of maternal vitamin C status on neurodevelopmental epigenetics.
format Online
Article
Text
id pubmed-8836017
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88360172022-02-12 The Epigenetic Role of Vitamin C in Neurodevelopment Coker, Sharna J. Smith-Díaz, Carlos C. Dyson, Rebecca M. Vissers, Margreet C. M. Berry, Mary J. Int J Mol Sci Review The maternal diet during pregnancy is a key determinant of offspring health. Early studies have linked poor maternal nutrition during gestation with a propensity for the development of chronic conditions in offspring. These conditions include cardiovascular disease, type 2 diabetes and even compromised mental health. While multiple factors may contribute to these outcomes, disturbed epigenetic programming during early development is one potential biological mechanism. The epigenome is programmed primarily in utero, and during this time, the developing fetus is highly susceptible to environmental factors such as nutritional insults. During neurodevelopment, epigenetic programming coordinates the formation of primitive central nervous system structures, neurogenesis, and neuroplasticity. Dysregulated epigenetic programming has been implicated in the aetiology of several neurodevelopmental disorders such as Tatton-Brown-Rahman syndrome. Accordingly, there is great interest in determining how maternal nutrient availability in pregnancy might affect the epigenetic status of offspring, and how such influences may present phenotypically. In recent years, a number of epigenetic enzymes that are active during embryonic development have been found to require vitamin C as a cofactor. These enzymes include the ten-eleven translocation methylcytosine dioxygenases (TETs) and the Jumonji C domain-containing histone lysine demethylases that catalyse the oxidative removal of methyl groups on cytosines and histone lysine residues, respectively. These enzymes are integral to epigenetic regulation and have fundamental roles in cellular differentiation, the maintenance of pluripotency and development. The dependence of these enzymes on vitamin C for optimal catalytic activity illustrates a potentially critical contribution of the nutrient during mammalian development. These insights also highlight a potential risk associated with vitamin C insufficiency during pregnancy. The link between vitamin C insufficiency and development is particularly apparent in the context of neurodevelopment and high vitamin C concentrations in the brain are indicative of important functional requirements in this organ. Accordingly, this review considers the evidence for the potential impact of maternal vitamin C status on neurodevelopmental epigenetics. MDPI 2022-01-21 /pmc/articles/PMC8836017/ /pubmed/35163133 http://dx.doi.org/10.3390/ijms23031208 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Coker, Sharna J.
Smith-Díaz, Carlos C.
Dyson, Rebecca M.
Vissers, Margreet C. M.
Berry, Mary J.
The Epigenetic Role of Vitamin C in Neurodevelopment
title The Epigenetic Role of Vitamin C in Neurodevelopment
title_full The Epigenetic Role of Vitamin C in Neurodevelopment
title_fullStr The Epigenetic Role of Vitamin C in Neurodevelopment
title_full_unstemmed The Epigenetic Role of Vitamin C in Neurodevelopment
title_short The Epigenetic Role of Vitamin C in Neurodevelopment
title_sort epigenetic role of vitamin c in neurodevelopment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836017/
https://www.ncbi.nlm.nih.gov/pubmed/35163133
http://dx.doi.org/10.3390/ijms23031208
work_keys_str_mv AT cokersharnaj theepigeneticroleofvitamincinneurodevelopment
AT smithdiazcarlosc theepigeneticroleofvitamincinneurodevelopment
AT dysonrebeccam theepigeneticroleofvitamincinneurodevelopment
AT vissersmargreetcm theepigeneticroleofvitamincinneurodevelopment
AT berrymaryj theepigeneticroleofvitamincinneurodevelopment
AT cokersharnaj epigeneticroleofvitamincinneurodevelopment
AT smithdiazcarlosc epigeneticroleofvitamincinneurodevelopment
AT dysonrebeccam epigeneticroleofvitamincinneurodevelopment
AT vissersmargreetcm epigeneticroleofvitamincinneurodevelopment
AT berrymaryj epigeneticroleofvitamincinneurodevelopment